Key result
Higher remnant cholesterol inflammatory index is linked to ~11% greater stroke risk per SD.
Why the study?
The joint impact of remnant cholesterol and high-sensitivity C-reactive protein on stroke risk remains unclear.
Does an elevated remnant cholesterol inflammatory index (RCII) predict an increased risk of incident stroke in adults aged 45 years or older?
Cohort (n=9,898)
Yes
Does an elevated remnant cholesterol inflammatory index (RCII) predict an increased risk of incident stroke in adults aged 45 years or older?
Hazard Ratio: 1.106 (95% CI 1.048–1.167)
Absolute Event Rate: 7.6% vs 3.5%
Elevated remnant cholesterol inflammatory index (RCII), integrating remnant cholesterol and hs-CRP, is significantly associated with an increased risk of incident stroke, particularly in males.
INTRODUCTION: Remnant cholesterol (RC) and high-sensitivity C-reactive protein (hs-CRP) are established stroke risk factors, but their joint impact remains unclear. OBJECTIVES: This study aimed to evaluate the predictive value of the remnant cholesterol inflammatory index (RCII), a novel index integrating RC and hs-CRP, in assessing stroke risk. METHODS: We analyzed 9,898 participants aged 45 years or older, with no history of stroke at baseline, from the China Health and Retirement Longitudinal Study (CHARLS). RCII was calculated using the formula: RCII = RC (mg/dL) × hs-CRP(mg/L)/10. A subset of 5,704 participants was studied to investigate the relationship between cumulative RCII exposure and stroke incidence. The associations of both baseline and cumulative RCII with stroke risk were assessed using Cox proportional hazards regression model. RESULTS: During a median 7-year follow-up, 560 participants (5.7 %) experienced an incident stroke. Stroke incidence escalated with increasing RCII quartiles, from 3.5 % (Q1) to 7.6 % (Q4). In multivariable-adjusted analyses, each standard deviation increase in RCII was significantly associated with a 10.6 % increased risk of stroke (HR = 1.106, 95 % CI: 1.048-1.167). ROC analysis revealed that RCII had the highest AUC at 0.581, higher than RC (0.566) and hs-CRP (0.560), though the difference with RC was not statistically significant (P = 0.166). Mediation analysis indicated a reciprocal mediation between RC and hs-CRP on stroke risk. In a 3-year subset analysis, 288 participants suffered a stroke. Participants with cumulative RCII levels exceeding 36.14 had a significantly increased risk of incident stroke (HR = 1.462, 95 % CI: 1.102-1.939). Subgroup analyses showed a significant positive association between elevated RCII levels and stroke risk in males, but not in females. CONCLUSIONS: Elevated levels of RCII, both at baseline and cumulative, are significantly associated with an increased risk of stroke. Early intervention in patients with high RCII may further help reduce stroke risk.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) conducted a cohort in Stroke risk (n=9,898). Remnant cholesterol inflammatory index (RCII) vs. Lower RCII levels was evaluated on Incident stroke (HR 1.106, 95% CI 1.048-1.167). Each standard deviation increase in the remnant cholesterol inflammatory index was associated with a 10.6% increased risk of incident stroke (HR 1.106; 95% CI 1.048-1.167).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: